Globus Medical and NuVasive: A Game-Changing Merger for Musculoskeletal Innovation
In a landmark move, Globus Medical, Inc. (NYSE: GMED), a trailblazing musculoskeletal solutions company, has officially sealed the deal in its highly anticipated merger with NuVasive, Inc. The outcome? A powerhouse alliance that’s set to redefine musculoskeletal care globally. This thrilling development comes with the promise of a comprehensive range of cutting-edge solutions and transformative technologies that will revolutionize patient care.
Dan Scavilla, the dynamic President and CEO of Globus Medical, shared his excitement, saying, “We’re embarking on an exhilarating journey to create a global musculoskeletal giant. Our unwavering commitment to improving patient lives drives us forward as we merge our unique portfolios and exceptional teams to expand the frontiers of spine and orthopedic care worldwide.”
The merger unites two industry titans, Globus Medical and NuVasive, combining their global reach, expansive commercial influence, extensive portfolios spanning spine and orthopedics, dedication to innovation and surgeon education, and enhanced operational capabilities. This partnership not only offers immense revenue potential but also boasts a robust financial foundation for value generation.
David Paul, the visionary Executive Chairman of Globus Medical, emphasized the significance of this merger, stating, “Our collaboration with NuVasive marks a pivotal moment in our company’s history. I take immense pride in the remarkable legacy we’ve built at Globus Medical and eagerly anticipate the myriad opportunities we will bring to surgeons and their patients as a united entity.”
Chris Barry, former CEO of NuVasive, added, “This merger with Globus Medical is nothing short of transformational, bringing together two leading companies sharing a common goal—changing more lives worldwide. I’m excited to contribute to the combined organization’s efforts in reshaping the future of surgery.”
Stay tuned as Globus Medical gears up to delve into the merger’s closing details and the exciting prospects it holds during its eagerly awaited third-quarter earnings conference call in November.
As part of the merger agreement with NuVasive, Globus Medical has expanded its board of directors from eight to eleven members, welcoming three accomplished NuVasive board members: John DeFord, Ph.D., Leslie V. Norwalk, Esq., and Daniel J. Wolterman. David Paul extended a warm welcome, saying, “I am delighted to welcome John, Leslie, and Dan to the Globus Board of Directors and am eager to collaborate with them in our ongoing mission to create lasting value for our patients, customers, and shareholders.”
The Nasdaq bid farewell to NuVasive common stock as of the close of trading on August 31, 2023. For more details about this momentous transaction, refer to the Form 8-Ks filed with the SEC today by NuVasive and Globus Medical.
Behind this groundbreaking merger, Goldman Sachs & Co. LLC provided financial guidance to Globus Medical, with legal counsel from Goodwin Procter LLP and Troutman Pepper. BofA Securities, Inc. served as NuVasive’s financial advisor, and Wachtell, Lipton, Rosen & Katz offered legal counsel.
About Globus Medical, Inc.
At Globus Medical, we’re not just in the business of healthcare; we’re on a mission to transform it. Our commitment is unwavering—to provide groundbreaking technologies and world-class clinical support that empower surgeons and healthcare providers to redefine patient care on a global scale. With one of the most comprehensive arrays of musculoskeletal solutions and enabling technologies, we’re not just changing the game; we’re rewriting the rules of the care continuum.
Now, with the seamless integration of NuVasive’s procedurally integrated portfolio, we’re elevating our commitment to the next level. As a united force, our passionate team is driven by a singular focus: advancing patient care beyond the limits of what was once possible.
Cautionary Notes on Forward-Looking Statements
In this communication, we embark on a journey through the realm of possibilities, guided by “forward-looking statements” within the intricate landscape of federal securities laws. These statements, vibrant and dynamic, venture into the world of expectations, financial performance, and conditions, painted with words like “expect,” “anticipate,” “intend,” and “believe,” where each brushstroke unveils the ever-shifting canvas of the future.
Yet, as we traverse this terrain of prospects, we must acknowledge the elements of uncertainty that lurk in the shadows. These forward-looking statements, while brimming with potential, are not unshakable guarantees. They dance on the fine line between aspiration and reality, influenced by risks, uncertainties, and assumptions that can sway them off course.
What are these elements of intrigue that might shape the future differently than envisioned? They include the vast macroeconomic landscape with its fluctuations, the combined company’s ability to adapt and flourish in the face of change, the acceptance of innovative surgical solutions by healthcare professionals, the ongoing development of new products, and the careful management of inventory.
But the story doesn’t end there. The narrative weaves through potential tax implications, litigation risks, market reactions, and the intricate art of business integration. It explores the ability to retain talent, the ever-shifting regulatory landscape, and a host of other factors outlined in annual reports.
In this epic tale of business transformation, we navigate through uncertainties, acknowledging that each twist and turn adds depth and complexity to the plot. While these risks are thoughtfully considered, we recognize that there may be hidden challenges not yet unveiled.
The consequences of these twists, whether they bring disruption or success, are part of the grand narrative. They have the power to shape the destiny of the combined company, affecting its financial condition, operations, and more.
And as we journey through these uncharted waters, both Globus Medical and NuVasive commit to transparency, promising to provide updates when the winds of change blow. We embark on this adventure with open eyes and a shared vision of what might be, ready to adapt and evolve as the story unfolds.